Twin Tree Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-48
Closed -$519 1872
2024
Q4
$568 Buy
+48
New +$567 ﹤0.01% 1541
2024
Q3
Sell
-78,156
Closed -$890K 1736
2024
Q2
$826K Buy
78,156
+62,542
+401% +$685K ﹤0.01% 1077
2024
Q1
$165K Sell
15,614
-36,200
-70% -$390K ﹤0.01% 1146
2023
Q4
$582K Buy
+51,814
New +$505K ﹤0.01% 1190

Other funds holding ROIV

Twin Tree Management's ROIV Position: Q1 2025 in Review

Twin Tree Management sold out of Roivant Sciences (ROIV) in Q1 2025, closing a stake of 48 shares — an estimated $519 sold.

Twin Tree Management first reported a position in ROIV in Q4 2023 and held it in 4 quarters. The position peaked at $826K in Q2 2024. 312 funds tracked by Wall St. Rank hold ROIV as of Q1 2025.

  • Twin Tree Management reported no remaining Roivant Sciences position as of Q1 2025 after selling out during the quarter.
  • Twin Tree Management sold 48 Roivant Sciences shares in Q1 2025, an estimated $519.
  • Twin Tree Management first reported a position in Roivant Sciences in Q4 2023 and held it in 4 quarters.
  • Twin Tree Management's Roivant Sciences position peaked at $826K in Q2 2024.
  • 312 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2025.

Based on Twin Tree Management's 13F filing for Q1 2025, filed 15 May 2025.